It’s not yet clear whether the iPad will live up to the breathless excitement that surrounded its launch. But, from the specs alone, it clearly spells trouble for dedicated e-readers, particularly Amazon’s larger version of the Kindle.
The Kindle DX is the same size as the iPad. It has a black and white E-Ink screen, four gigabytes of internal storage, 3G access and costs $489. Meanwhile, the cheapest version of the iPad has a full-color touch screen, a powerful processor and graphics chip, 16 gigabytes of flash storage, Wi-Fi and sells for $499.
The cheaper iPad might not have 3G or the same battery life as the Kindle DX (up to four days), but on every other count it wins. It has both a gorgeous screen and vastly more functionality. And, while Amazon has established an excellent, easy way to buy books, iTunes, which already has some 125 million customers, will give it a run for its money.
During today’s launch, Apple played down its move into the e-reader market–the iBooks demo was buried in-between game demonstrations and a long explanation of the company’s productivity software. But the iPad price point means that those considering a dedicated e-reader will be sorely tempted by an iPad. In addition, because an iTunes account can be used to purchase e-books, Apple stands to capture a large audience of users readers who want to read a few e-books but would never buy a dedicated device.
The iBooks app also has access to the full catalogs of five major publishers: Penguin, HarperCollins, Simon & Schuster, Macmillan, and Hachette Book Group. It also uses the standard ePub format, meaning that books purchased on this device will be compatible with other readers.
These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.
Why China is still obsessed with disinfecting everything
Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.
Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.
A quick guide to the most important AI law you’ve never heard of
The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.